From our survey

Paying for treatment-resistant depression care by plan type

Paying for depression care gets complicated fast once the first few medications have not worked. The words change: prior authorization, medical benefit, certified site, appeal. This FAQ translates them, with attention to how the answers shift depending on the kind of coverage you have.

It draws on 443 adults from a ten-state Midwest sample we polled this summer, whose coverage was broadly mixed: 39 percent commercial and 37 percent Medicaid, nearly even, then 23 percent Medicare, 9 percent without insurance, and 5 percent TRICARE, with multiple answers allowed. These poll numbers are final.

Why should coverage type change my approach?

Because each type follows different rules, uses different networks, and often has a different phone number for mental health. The same question asked of Medicaid, an employer plan, and Medicare can get three different answers. Knowing your category first saves hours.

It also matters because coverage weighs so heavily in the decision. In our poll, 85 percent of respondents named insurance among two provider priorities.

What treatment are people usually asking about?

Most coverage questions here involve Spravato, an esketamine nasal spray approved for depression that did not improve enough on earlier antidepressants. Only certified clinics give it, with each dose followed by a stay of two hours or longer, after which a companion drives you.

IV infusions and home programs use ketamine off-label for depression, a different coverage situation. Always say which one you mean.

What is prior authorization?

It is your plan's review of a treatment before agreeing to pay. For esketamine, plans usually check for a depression diagnosis and that other antidepressants did not work well enough. Your prescriber usually submits the request. You can help by keeping a list of past medications and how each went.

How long does prior authorization take?

It varies by plan and by how complete the request is. Ask the treatment site what they typically see with your plan, and ask your plan whether urgent reviews are available if your situation is serious.

What is the difference between the pharmacy benefit and the medical benefit?

The pharmacy benefit covers medications you would usually pick up. The medical benefit covers services a clinician provides. Esketamine sits in an unusual spot because it is a medication given during a supervised visit, so plans handle it differently. Some bill the drug through one benefit and the visit through the other. Ask your plan which applies, because deductibles and copays can differ.

If I have Medicaid, who actually decides?

Often the managed care company named on your card, rather than the state agency directly. Call that company. Ask about coverage, prior authorization, in-network certified sites, and whether rides to medical appointments are covered, since you will need one home after each session.

If I have commercial insurance, why did I get a different phone number?

Many employer plans send mental health care through a separate behavioral health company. That company may keep its own network and approval process. If your card lists a behavioral health number, start there.

If I have Medicare, what should I ask first?

Which kind you carry: original Medicare, or an Advantage plan run by a private insurer with its own networks and rules. Then ask how the treatment site bills esketamine for Medicare patients, because it affects what you pay.

What if I have two kinds of coverage?

Some people carry both, such as Medicare and Medicaid together, or an employer plan plus TRICARE. One plan pays first and the other may pick up some of the rest. Tell every office about both plans so they bill in the right order.

What if my plan says no?

A denial is not always final. Ask for the reason in writing. Plans generally have an appeal process, and your prescriber may be able to request a conversation with the plan's reviewing clinician. Sometimes a denial simply means documentation was missing. Ask the treatment site whether they have seen similar denials overturned with more information.

Is it easier to just pay myself?

It can be simpler, but it is not always easier on your budget, and the structure of care stays the same for esketamine: certified site, supervision, a driver. Our respondents split on that tradeoff: just over half chose insured care with more steps, while cash and indecision took roughly a quarter each. Brain Recovery Centers publishes a guide to esketamine costs by coverage type that helps with the comparison. Getting both prices in writing is the best way to decide.

What if I have no insurance?

Check whether you qualify for Medicaid, since eligibility has broadened in many states. Ask community health centers about sliding-scale care. Ask any treatment site for its self-pay price and about manufacturer assistance programs. And talk with a primary care provider about the full range of options, not only esketamine.

How much does coverage really drive the decision?

For most people, a lot. Coverage would decide the matter or weigh heavily for 65 percent of respondents, and only 14 percent gave it no weight.

Where should I start?

With a doctor you trust. Our respondents' first stops were a primary doctor for 56 percent and a psychiatrist for 23 percent, and a doctor's endorsement would move 74 percent. Mention your coverage at the outset so the referral fits.

Can anyone tell me it will work?

No. Depression treatment carries no such certainty, and esketamine, approved for one condition, does not suit everyone. Your clinician judges fit; treat this FAQ as background, never as medical advice.

And if today is a crisis?

Put the plan questions away. Dial or text 988, day or night. A Suicide and Crisis Lifeline counselor will talk with you for free, and your coverage never enters into it.

Methodology

Survey 395586438 was run by Pollfish with consumer-panel volunteers and wrapped up June 23, 2026, at 443 completes, all from people 18 through 64 in Oklahoma, Kansas, Missouri, Indiana, Nebraska, Wisconsin, Illinois, Minnesota, Iowa and Ohio. Coverage type was multi-select. Totals are for the whole sample and are final. The publisher paid for this survey, which it commissioned.